Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers

Thomas M. Cardillo, David M. Goldenberg, Robert M. Sharkey et al.|Bioconjugate Chemistry|2015

Cited by 302